Drug pricing is an increasingly complex area that combines business knowledge, the review of difficult and sometimes ambiguous regulations, and the understanding of industry practices. Our team regularly provide advice, in-depth analyses and internal training on calculating the various pricing metrics that are reported to federal agencies or that set price ceilings (e.g., AMP, Best Price, Section 340B, ASP, non-FAMP, and federal ceiling price), and on related reporting and administrative requirements. We at Arnold & Porter are here to help.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.